Legal & General Group’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-38
| Closed | -$46 | – | 3458 |
|
|
2025
Q1 | $46 | Sell |
38
-2,444
| -98% | -$2.96K | ﹤0.01% | 3375 |
|
|
2024
Q4 | $3.2K | Hold |
2,482
| – | – | ﹤0.01% | 3364 |
|
|
2024
Q3 | $6.83K | Hold |
2,482
| – | – | ﹤0.01% | 3339 |
|
|
2024
Q2 | $5.6K | Buy |
+2,482
| New | +$5.6K | ﹤0.01% | 3370 |
|
|
2021
Q2 | – | Sell |
-4,552
| Closed | -$10K | – | 3557 |
|
|
2021
Q1 | $10K | Hold |
4,552
| – | – | ﹤0.01% | 3376 |
|
|
2020
Q4 | $10K | Hold |
4,552
| – | – | ﹤0.01% | 3340 |
|
|
2020
Q3 | $12K | Sell |
4,552
-1,988
| -30% | -$5.24K | ﹤0.01% | 3155 |
|
|
2020
Q2 | $20K | Sell |
6,540
-338
| -5% | -$1.03K | ﹤0.01% | 3068 |
|
|
2020
Q1 | $13K | Sell |
6,878
-2,388
| -26% | -$4.51K | ﹤0.01% | 3077 |
|
|
2019
Q4 | $27K | Buy |
9,266
+1,600
| +21% | +$4.66K | ﹤0.01% | 3095 |
|
|
2019
Q3 | $28K | Buy |
7,666
+2,305
| +43% | +$8.42K | ﹤0.01% | 2995 |
|
|
2019
Q2 | $22K | Buy |
+5,361
| New | +$22K | ﹤0.01% | 3159 |
|